Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.170
-0.260 (-7.58%)
At close: May 9, 2025, 4:00 PM
3.320
+0.150 (4.73%)
After-hours: May 9, 2025, 5:35 PM EDT

Voyager Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-84.69-65132.33-46.41-71.236.74
Upgrade
Depreciation & Amortization
4.554.734.446.195.173.82
Upgrade
Loss (Gain) From Sale of Assets
0.480.510.180.38--
Upgrade
Asset Writedown & Restructuring Costs
2.782.78----
Upgrade
Loss (Gain) From Sale of Investments
-7.04-7.97-3.63-0.020.350.03
Upgrade
Stock-Based Compensation
14.8914.7911.159.3411.3214.93
Upgrade
Other Operating Activities
0.16---2.47-2.46-7.7
Upgrade
Change in Accounts Receivable
1.3581.31-83.230.487.2810.48
Upgrade
Change in Accounts Payable
-4.952.39-0.961.99-0.06-3.44
Upgrade
Change in Unearned Revenue
-38.74-44.849.4123.73-1.72-150.68
Upgrade
Change in Other Net Operating Assets
-0.76-48.23-5.73-2.21-0.91
Upgrade
Operating Cash Flow
-111.97-15.3177.92-12.51-53.53-96.72
Upgrade
Capital Expenditures
-2.04-3.52-3.26-2.49-1.61-12.1
Upgrade
Investment in Securities
44.45-91.34-138.39-4.8567.52125.09
Upgrade
Investing Cash Flow
42.41-94.86-141.64-7.3465.91113
Upgrade
Issuance of Common Stock
1.24114.0233.651.110.613.16
Upgrade
Financing Cash Flow
1.24114.0233.651.110.613.16
Upgrade
Net Cash Flow
-68.323.85-30.08-18.7412.9919.44
Upgrade
Free Cash Flow
-114.01-18.8374.66-15-55.13-108.81
Upgrade
Free Cash Flow Margin
-170.27%-23.54%29.86%-36.67%-147.36%-63.59%
Upgrade
Free Cash Flow Per Share
-1.97-0.331.68-0.39-1.46-2.91
Upgrade
Levered Free Cash Flow
-77.9425.61-3.017.253.94-19.99
Upgrade
Unlevered Free Cash Flow
-77.9425.61-3.017.254.18-19.99
Upgrade
Change in Net Working Capital
33.45-59.9491.61-22.86-35.3143.76
Upgrade
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q